000 01119 a2200313 4500
005 20250517025525.0
264 0 _c20150804
008 201508s 0 0 eng d
022 _a1474-4457
024 7 _a10.1016/S1473-3099(15)70080-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Schalkwyk, Donelly A
245 0 0 _aMalaria resistance to non-artemisinin partner drugs: how to reACT.
_h[electronic resource]
260 _bThe Lancet. Infectious diseases
_cJun 2015
300 _a621-3 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aAntimalarials
_xtherapeutic use
650 0 4 _aArtemisinins
_xtherapeutic use
650 0 4 _aDrug Resistance
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMalaria, Falciparum
_xdrug therapy
650 0 4 _aMale
650 0 4 _aPlasmodium falciparum
_xdrug effects
650 0 4 _aQuinolines
_xtherapeutic use
700 1 _aSutherland, Colin J
773 0 _tThe Lancet. Infectious diseases
_gvol. 15
_gno. 6
_gp. 621-3
856 4 0 _uhttps://doi.org/10.1016/S1473-3099(15)70080-0
_zAvailable from publisher's website
999 _c24808623
_d24808623